|
|
Volumn 19, Issue 2, 2001, Pages 251-254
|
|
Two years' experience with Dialock® and CLS™ (A new antimicrobial lock solution)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
CITRIC ACID;
CLS;
TAUROLIDINE;
ADULT;
AGED;
ANTIBIOTIC THERAPY;
BACTEREMIA;
CATHETER INFECTION;
CENTRAL VENOUS CATHETER;
CONFERENCE PAPER;
CONTROLLED STUDY;
DEMOGRAPHY;
DEVICE;
DRUG DELIVERY SYSTEM;
DRUG EFFECT;
DRUG SAFETY;
EVALUATION;
FEMALE;
HEMODIALYSIS;
HUMAN;
IMPLANTATION;
INFUSION;
INTERNAL JUGULAR VEIN;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
SEPSIS;
SIDE EFFECT;
ADULT;
ANTI-INFECTIVE AGENTS;
ANTICOAGULANTS;
CATHETERIZATION, CENTRAL VENOUS;
CATHETERS, INDWELLING;
CITRIC ACID;
EQUIPMENT DESIGN;
FEMORAL VEIN;
HEART ATRIA;
HUMANS;
INCIDENCE;
INFECTION CONTROL;
JUGULAR VEINS;
KIDNEY FAILURE, CHRONIC;
PILOT PROJECTS;
RENAL DIALYSIS;
RETROSPECTIVE STUDIES;
RISK ASSESSMENT;
SAFETY;
SEPSIS;
SOLUTIONS;
SUBCLAVIAN VEIN;
TAURINE;
THIADIAZINES;
|
|
EID: 0035162149
PISSN: 02535068
EISSN: None
Source Type: Journal
DOI: 10.1159/000046950 Document Type: Conference Paper |
|
Times cited : (57)
|
|
References (18)
|
